Journal of Transcatheter Valve Therapies (JTVT) is a peer-reviewed, open access journal publishing articles on Transcatheter Valve Therapies. Published continuously online, the journal is fully indexed in J-STAGE. JTVT welcomes submissions from around the world.

About the journal

Journal of Transcatheter Valve Therapies is an official journal of Japan Transcatheter Valve Therapies (Society) .

Read more >

Instructions to Authors

Journal of Transcatheter Valve Therapies supplies comprehensive and clear Instructions to Authors, which offer guidance on article types and format, journal policies, and how to submit manuscripts.

Read more >

The journal welcomes submissions from around the world. Please consult the Instructions to Authors and the Author Checklist.

Latest articlesView more articles >

Case ReportJune 28, 2024

A Successful Case of Percutaneous Transluminal Mitral Commissurotomy in Acute Heart Failure from Exacerbation of Mitral Stenosis Following Transcatheter Aortic Valve Implantation

Toshiaki Yamanaka, Mayuko Imamura, Takefumi Oka, Shunsuke Kubo

Objective: Worsening of mitral stenosis (MS) following transcatheter aortic valve implantation (TAVI) is rare, and the precise effect of percutaneous transluminal mitral commissurotomy (PTMC) on MS progression following TAVI remains unclear. We performed PTMC in patients with acute heart failure attributed to MS exacerbation following TAVI. Case Presentation: An 88-year-old woman presenting with exertional dyspnea was admitted to our facility.

Read full Article >

Original ArticleMay 28, 2024

N-Terminal Pro-B-Type Natriuretic Peptide for Predicting Early Left Ventricular Ejection Fraction Recovery after Transcatheter Aortic Valve Implantation: A Preliminary Report

Ryohei Akashi, Seiji Koga, Tomohiro Honda, Daisuke Sato, Chisa Eguchi, Ichiro Matsumaru, Tsuyoshi Yonekura, Tsuyoshi Yoshimuta, Satoshi Ikeda, Hiroaki Kawano, Takashi Miura, Koji Maemura

Objective: To examine the relationship between baseline N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels and early recovery of the left ventricular ejection fraction (LVEF) after transcatheter aortic valve implantation (TAVI) in patients with severe aortic stenosis (AS).

Read full Article >

Original ArticleMay 21, 2024

Prognostic Impact of Peak Tricuspid Regurgitation Velocity in Patients Undergoing Transcatheter Aortic Valve Implantation

Kayo Sugiyama, Masato Tochii, Masanobu Fujimoto, Wataru Suzuki, Hirotaka Watanuki, Daisuke Koiwa, Tetsuya Amano, Katsuhiko Matsuyama

Objective: No appropriate guidelines concerning perioperative management of transcatheter aortic valve implantation (TAVI) exist for patients with aortic valve stenosis (AS) and concomitant pulmonary hypertension. Peak tricuspid regurgitation velocity (PTRV) has been estimated to be a non-invasive representation of pulmonary artery pressure.

Read full Article >